{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:31:08Z","timestamp":1790155868127,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"LABEX SynOrg","award":["ANR-11-LABX-0029"],"award-info":[{"award-number":["ANR-11-LABX-0029"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejmech.2018.01.086","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:25:59Z","timestamp":1517405159000},"page":"678-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates"],"prefix":"10.1016","volume":"146","author":[{"given":"Maxime","family":"Bessi\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Hervin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Lohier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi A.","family":"Agrofoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.086_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.01.086_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A\u00a0novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.01.086_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3851\/IMP2012","article-title":"Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy","volume":"22","author":"Pertusati","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/med.21296","article-title":"Medicinal chemistry of fluorinated cyclic and acyclic nucleoside phosphonates","volume":"33","author":"Baszczynski","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.01.086_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0706446","article-title":"Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy","volume":"147","author":"De Clercq","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.086_bib6","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of nucleoside phosphate and phosphonate prodrugs","volume":"114","author":"Pradere","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.01.086_bib7","doi-asserted-by":"crossref","first-page":"10400","DOI":"10.1021\/acs.jmedchem.6b00523","article-title":"Nucleoside phosphate and phosphonate prodrug clinical candidates","volume":"59","author":"Thornton","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.01.086_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0166-3542(92)90084-I","article-title":"Synthesis and in\u00a0vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine","volume":"19","author":"Starrett","year":"1992","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.01.086_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/AAC.40.1.22","article-title":"Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine","volume":"40","author":"Naesens","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/AAC.42.7.1568","article-title":"Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)9-(2-phosphonylmethoxypropyl)adenine in mice","volume":"42","author":"Naesens","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2015.11.009","article-title":"Tenofovir alafenamide: a novel prodrug of tenofovir for treatment of Human Immunodeficiency Virus","volume":"125","author":"Ray","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.01.086_bib13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/1060028016660812","article-title":"Tenofovir alafenamide","volume":"50","author":"Gibson","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib14","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/AAC.49.5.1898-1906.2005","article-title":"Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.01.086_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: past, present and future: bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge","volume":"73","author":"De Clercq","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.086_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm1011462","article-title":"Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates","volume":"54","author":"Topalis","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/17425240902824808","article-title":"Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues","volume":"6","author":"Peterson","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2018.01.086_bib19","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/jm701260b","article-title":"Prodrugs of phosphates and phosphonates","volume":"51","author":"Hecker","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z","article-title":"Pronucleotides: toward the in\u00a0vivo delivery of antiviral and anticancer nucleotides","volume":"20","author":"Wagner","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.01.086_bib21","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1016\/j.tet.2011.05.017","article-title":"Expeditious convergent procedure for the preparation of bis(POC) prodrugs of new (E)-4-phosphono-but-2-en-1-yl nucleosides","volume":"67","author":"Montagu","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.01.086_bib22","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1002\/ejoc.201101111","article-title":"The Shortest strategy for generating phosphonate prodrugs by olefin cross-metathesis - application to acyclonucleoside phosphonates","volume":"2011","author":"Prad\u00e8re","year":"2011","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2012.08.042","article-title":"Synthesis and antiviral evaluation of bis(POM) prodrugs of (E)-[4\u2019-phosphono-but-2\u2019-en-1\u2019-yl]purine nucleosides","volume":"57","author":"Prad\u00e8re","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib24","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1021\/ol401922r","article-title":"The preparation of trisubstituted alkenyl nucleoside phosphonates under ultrasound-assisted olefin cross-metathesis","volume":"15","author":"Sari","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.01.086_bib25","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1002\/slct.201600879","article-title":"Sonication-assisted synthesis of (E)-2-methyl-but-2-enyl nucleoside phosphonate prodrugs","volume":"1","author":"Bessi\u00e8res","year":"2016","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2018.01.086_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2009.01.005","article-title":"Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art","volume":"82","author":"Hostetler","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2018.01.086_bib27","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/cmdc.200900289","article-title":"Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells","volume":"4","author":"Mehellou","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.01.086_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1389557043403936","article-title":"Aryloxy phosphoramidate triesters as Pro-Tides","volume":"4","author":"Cahard","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1081\/NCN-100002496","article-title":"Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA in blood","volume":"20","author":"Eisenberg","year":"2001","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2018.01.086_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/AAC.01215-07","article-title":"Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131","volume":"52","author":"Cihlar","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1081\/NCN-100002338","article-title":"Practical synthesis, separation, and stereochemical assignment of the PMPA prodrug GS-7340","volume":"20","author":"Chapman","year":"2001","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2018.01.086_bib32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/adsc.200900134","article-title":"Stability of second generation Grubbs' alkylidenes to primary amines: formation of novel ruthenium-amine complexes","volume":"351","author":"Wilson","year":"2009","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2018.01.086_bib33","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0040-4020(00)01143-1","article-title":"O-Ethyl 1-azidoalkylphosphonic acids versatile reagents for the synthesis of protected phosphonoamidate peptides","volume":"57","author":"Sikora","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.01.086_bib34","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.3390\/molecules17033359","article-title":"Synthesis of azanucleosides through regioselective ring-opening of epoxides catalyzed by sulphated zirconia under microwave and solvent-free conditions","volume":"17","author":"Hernandez-Reyes","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.01.086_bib35","doi-asserted-by":"crossref","first-page":"59747","DOI":"10.1039\/C4RA13033B","article-title":"A\u00a0convenient, highly selective and eco-friendly N-Boc protection of pyrimidines under microwave irradiation","volume":"4","author":"Bessi\u00e8res","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.01.086_bib36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1021\/ol990909q","article-title":"Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands","volume":"1","author":"Scholl","year":"1999","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.01.086_bib37","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1021\/ja001179g","article-title":"Efficient and recyclable monomeric and dendritic Ru-based metathesis catalysts","volume":"122","author":"Garber","year":"2000","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.086_bib38","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/jm900047j","article-title":"Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective Falcipain-2 inhibitors","volume":"52","author":"Ettari","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/ol047356q","article-title":"Lewis acid assisted ring-closing metathesis of chiral diallylamines:\u2009 an efficient approach to enantiopure pyrrolidine derivatives","volume":"7","author":"Yang","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2018.01.086_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/b719493e","article-title":"Olefin metathesis in water using acoustic emulsification","volume":"10","author":"Gu\u0142ajski","year":"2008","journal-title":"Green Chem."},{"key":"10.1016\/j.ejmech.2018.01.086_bib41","series-title":"Olefin Metathesis","first-page":"515","article-title":"Olefin metathesis in water and aqueous media","author":"Lipshutz","year":"2014"},{"key":"10.1016\/j.ejmech.2018.01.086_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.34.6.1061","article-title":"Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1","volume":"34","author":"Schinazi","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.01.086_bib43","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/AAC.46.12.3854-3860.2002","article-title":"Antiviral activities and cellular toxicities of modified 2\u2032,3\u2032-dideoxy-2\u2032,3\u2032-didehydrocytidine analogues","volume":"46","author":"Stuyver","year":"2002","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T14:43:00Z","timestamp":1603723380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418301089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"alternative-id":["S0223523418301089"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.086","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}